- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05823051
The Effect of Video-Assisted Sudden Infant Death Syndrome Prevention Training Program and Counseling Practice on Mothers' Knowledge Level and Self-efficacy: Randomized Controlled Study
Akdeniz University
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Sudden Infant Death Syndrome (SIDS) is one of the leading causes of infant mortality in the postneonatal period, but it can be prevented and its incidence can be reduced by creating a safe sleep environment with modifiable risk factors. It is known that parents, infant care providers and health professionals do not have sufficient knowledge about SIDS and safe sleep, and especially mothers exhibit many risky behaviors in terms of SIDS, such as using the wrong sleeping positions while putting their babies to sleep. Therefore, it is of utmost importance to inform and raise awareness of parents on the issues of SIDS and safe sleep, which remain important today, on the premise of promoting public health. In addition, informing mothers about the risk factors to protect their babies from SIDS, encouraging them to create and maintain a safe sleep environment, and ensuring that they are pioneers in this regard are also of great importance in terms of sharing information with other infant care providers in their social life. SIDS occurs in the postpartum period and has high values in infant mortality rates. For this reason, it is predicted that awareness on this issue will be significantly increased by providing education to new mothers at the earliest period and that SIDS can be prevented significantly by providing safe sleep environments. At the same time, based on the effect of self-efficacy perceptions of new mothers on the care of the baby, it is thought that the training and counseling practice planned to be given to mothers about SIDS will have a positive effect on the self-efficacy perceptions of mothers. When the relevant literature was examined, it was found that there were not enough studies on this subject in our country.
The aim of this study was to evaluate the effect of video-assisted Sudden Infant Death Syndrome prevention training program and counseling on mothers' knowledge level and self-efficacy.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Dilara AYDIN TOZLU, Master's degree
- Email: dilara.aydinn.da@gmail.com
Study Contact Backup
- Name: Emine EFE, Professor
- Phone Number: 02423106103
- Email: eefe@akdeniz.edu.tr
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- The one who has just given birth,
- With a healthy newborn baby,
- Speaks, understands and can read and write Turkish and has no barriers to communication,
- Able to use the internet, telephone and e-mail actively,
- Mothers who voluntarily agreed to participate in the study will be included.
Exclusion Criteria:
- Have not attended at least 3 sessions of the training program,
- Mothers who indicate that they want to leave the study while the research is ongoing will be excluded.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: VASIDS-TP and Counseling Practice
Video-Assisted Sudden Infant Death Syndrome Prevention Training Program (VASIDS-TP) and Counseling Practice
|
VASIDS-TP will be implemented online as an individual training to the intervention group through the Microsoft Teams program, to be completed in 5 days-5 sessions in the time frames determined by the participants.
The consultancy practice will start with a pre-test and participants will be assured that they can call the researcher 24/7, and the consultancy practice will be continued by phone call or messaging.
|
No Intervention: Routine Care
The control group will receive routine care in the obstetric ward. A pre-test will be conducted using the Google Survey form. "Personal Information Form", "Sudden Infant Death Syndrome Knowledge Level Assessment Form" (Pre-Test) and "General Self-Efficacy Scale" will be completed at this stage. The mothers in the control group will receive the training included in clinical routine care. The mothers in this group will not receive any planned structured training by the researchers during the study. The mothers in the control group will be administered the "Sudden Infant Death Syndrome Knowledge Level Assessment Data Form" and the "General Self-Efficacy Scale" with the Google survey that will be sent to their phones 1 month after the pre-test application. After the completion of the study, the control group will receive the same intervention (VASIDS-TP) as the intervention group. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sudden Infant Death Syndrome Knowledge Level Assessment Form 1
Time Frame: Before the training
|
This form was developed by the researchers in line with the literature and consists of 33 items to measure the level of knowledge about SIDS.
|
Before the training
|
Sudden Infant Death Syndrome Knowledge Level Assessment Form 2
Time Frame: 1 month after the training
|
This form was developed by the researchers in line with the literature and consists of 33 items to measure the level of knowledge about SIDS.
|
1 month after the training
|
General Self-Efficacy Scale 1
Time Frame: Before the training
|
"General Self-Efficacy Scale" is a five-point Likert-type scale consisting of 17 items.
The question "How well does it describe you?" has five options ranging from "not at all" to "very well".
The total score of the scale ranges between 17-85, and the higher the score, the higher the self-efficacy belief.
|
Before the training
|
General Self-Efficacy Scale 2
Time Frame: 1 month after the training
|
"General Self-Efficacy Scale" is a five-point Likert-type scale consisting of 17 items.
The question "How well does it describe you?" has five options ranging from "not at all" to "very well".
The total score of the scale ranges between 17-85, and the higher the score, the higher the self-efficacy belief.
|
1 month after the training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Personal Information Form
Time Frame: Before the training
|
The "Personal Information Form" developed by the researchers in line with the literature includes multiple-choice questions about mother, baby and sleep environment.
|
Before the training
|
DISCERN Scale
Time Frame: After the training videos are created
|
The training videos developed by the researchers will be evaluated by experts using DISCERN.
Basically, it was developed to assess the quality of written and technology-based educational materials prepared to inform individuals about health and treatment options.
The DISCERN scale consists of 16 items and each question is scored from 1 to 5. A score in the range of 15-75 is obtained by summing the responses from each item.
In the evaluation, a low total score indicates poor quality and a high score indicates good quality.
|
After the training videos are created
|
System Usability Scale (SUS)
Time Frame: Pre-application
|
In the test phase of the developed VASIDS-TP, SUS will be applied to evaluate the experiences of mothers (users).
The whole scale consists of 10 questions.
Each question has a value from 1 to 5 according to the answer given.
SUS Score value is obtained between 0-100.
SUS Score values of 68 points and above are considered above average, while values below 68 points are considered below average.
|
Pre-application
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- AUDilaraAT
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sudden Infant Death
-
Children's Hospital Medical Center, CincinnatiEvery Child Succeeds; de Cavel Family SIDS FoundationCompletedSudden Infant Death Syndrome (SIDS)United States
-
University of VirginiaBoston University; Washington University School of Medicine; National Institute... and other collaboratorsRecruitingInfant Death | Breastfeeding | Sudden Infant Death Syndrome Without Mention of AutopsyUnited States
-
Johns Hopkins UniversityNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingSudden Infant Death | Sudden Unexplained Infant DeathUnited States
-
Johns Hopkins Bloomberg School of Public HealthEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedSudden Infant Death SyndromeUnited States
-
Nantes University HospitalAXA Assurances VIE MutuelleNot yet recruitingSudden Infant Death | Sudden Unexplained Infant DeathFrance
-
Rachel Moon, MDCompletedSudden Infant Death SyndromeUnited States
-
National Center for Research Resources (NCRR)CompletedSudden Infant Death Syndrome
-
University of VirginiaNational Center for Research Resources (NCRR); March of DimesCompletedSudden Infant Death SyndromeUnited States
-
Johns Hopkins UniversityAmerican SIDS InstituteNot yet recruitingSudden Infant Death
-
Ziv HospitalUnknownSudden Infant DeathIsrael
Clinical Trials on VASIDS-TP and Counseling Practice
-
Rutgers, The State University of New JerseyColorado Department of Public Health and Environment; University of New MexicoCompletedBreast Cancer | Ovarian CancerUnited States
-
University of North Carolina, Chapel HillCompletedPelvic Organ ProlapseUnited States
-
Fox Chase Cancer CenterCompleted
-
Duke UniversityCompletedDrug Related Problems Post Hospital Discharge | Healthcare Utilization | Discharge Medication CounselingUnited States
-
University of LouisvilleCompleted
-
Thomas Jefferson UniversityActive, not recruiting
-
Sumitomo Pharma America, Inc.Recruiting
-
Tarsus Pharmaceuticals, Inc.CompletedBlepharitisUnited States
-
National Taiwan University HospitalUnknown
-
Sumitomo Pharma America, Inc.TerminatedChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma | CLL | SLLUnited States